Olympus further clarifies device use after serious injuries and death

The update is intended to cut the risk of endobronchial combustion that has been linked to serious injuries and one death.

Edwards CFO Scott Ullem to exit post

Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.

Dexcom execs say company has fixed G7 quality problems

After dealing with a deployment issue with glucose monitors earlier this year, interim CEO Jake Leach said improving customer service has also been a focus for the company.

Agilent selects Adam Elinoff as CFO

The appointment fills a position made available when Bob McMahon resigned as CFO on July 31.

3 takeaways from TCT 2025

Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

Philips receives FDA warning letter over quality issues

The notice follows inspections of three Philips facilities that found failures to meet standards for reporting complaints and corrective actions.

US to lower China tariffs as part of trade war truce

The truce also includes de-escalating other trade actions, such as China's rare earth export controls and U.S. investigations into China-linked ships.

Medline files for initial public offering

The medical and surgical products provider could reportedly raise $5 billion at a $50 billion valuation.

CMS grants NCD for renal denervation, benefiting Medtronic, Recor

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.

Zimmer wins FDA’s breakthrough status for tech to prevent joint infections

Integrating a controlled-release iodine layer into hip implants could reduce the rate of potentially fatal infections.

Thermo Fisher to acquire clinical trial data firm Clario for $8.9B

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.

J&J partners with Nvidia on AI for kidney stone procedures

The medtech firm is using Nvidia’s technology in its Monarch robotic platform for urology.

Olympus execs talk about import alert, GI robot and AI

CEO Bob White and Chief Strategy Officer Gabriela Kaynor discussed the medtech company’s quality and technology priorities after a year of change.

Medtronic links renal denervation to 3-year blood pressure reduction

Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

Corcym, CardioPrecision set sights on robotic heart valve replacement

The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.

Health systems are racing to adopt AI. But can they prove its value?

Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, like provider and patient satisfaction, are important too — and also impact providers’ bottom lines.

J&J awards first grants from AI surgery fund

Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.

CMS calls back furloughed employees to help with Medicare, ACA enrollment periods

Roughly 3,000 employees are coming back to work on Monday, funded by user fees as the shutdown drags into its fourth week.

Medtech industry closely watching Section 232 investigation

The investigation, which could be used to impose tariffs for medical products, has raised the attention of several industry groups. Check out MedTech Dive’s roundup of coverage on the 232 probe.

Accuray hires Steve La Neve as CEO in transformation effort

The radiotherapy systems maker unveiled the leadership change and strategy initiatives as it reported a preliminary fiscal first-quarter adjusted loss.